The Promise of Digital Therapeutics for ADHD: Transforming Care Now and in the Future
As digital therapeutics (DTx) gain traction in the management of attention-deficit/hyperactivity disorder (ADHD), they offer new hope for the millions affected by this neurodevelopmental condition. By harnessing the power of technology to deliver personalized, data-driven interventions, DTx are reshaping the landscape of ADHD care. While still an emerging field, the evidence base supporting DTx for ADHD is growing rapidly, highlighting their potential to improve outcomes, expand access to care, and empower patients and families.